89 related articles for article (PubMed ID: 3728241)
21. [Effects of intravenous urography using sodium and meglumine ioxitalamate (Telebrix 38) on blood creatinine and urinary excretion of N-acetyl-beta-D-glucosaminidase].
Lacour B; Lacroix C; Jungers P; Bailly M
Ann Biol Clin (Paris); 1984; 42(6):407-11. PubMed ID: 6532266
[TBL] [Abstract][Full Text] [Related]
22. [Changes in N-acetyl-beta-glucosaminidase (NAG) in prostatitis patients].
Yasumoto R; Kobayakawa H; Kakinoki K; Iseki T; Umeda M; Kawashima H; Moriya K; Maekawa M
Hinyokika Kiyo; 1986 Jun; 32(6):841-5. PubMed ID: 3766344
[TBL] [Abstract][Full Text] [Related]
23. [Determination of urinary NAG isozyme by thermal inactivation and the age difference].
Asami T; Nakano T; Sakai K
Rinsho Byori; 1989 Sep; 37(9):1051-5. PubMed ID: 2607658
[TBL] [Abstract][Full Text] [Related]
24. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
25. [Antineoplastic therapy and urinary enzymes. Preliminary note on the determination of urinary N-acetyl-beta-D-glucosaminidase in patients treated with cisplatin].
Crovato E; Salvini R
Boll Soc Ital Biol Sper; 1984 Dec; 60(12):2255-60. PubMed ID: 6543318
[TBL] [Abstract][Full Text] [Related]
26. [Fundamental studies on the measurement of urinary NAG and determination of the normal values for NAG activity in various age groups].
Iimura Y; Shimada I; Ohnuki Y; Noguchi H; Kawai T; Asano Y; Kawana H
Rinsho Byori; 1983 Feb; 31(2):179-84. PubMed ID: 6854998
[No Abstract] [Full Text] [Related]
27. Proximal tubule damage in patients treated with gentamicin or amikacin.
Wiland P; Szechciński J
Pol J Pharmacol; 2003; 55(4):631-7. PubMed ID: 14581723
[TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of urinary N-acetyl-beta-D-glucosaminidase activity in patients receiving aminoglycoside and cephalosporin drugs.
Naruse T; Hirokawa N; Oike S; Maekawa T
Res Commun Chem Pathol Pharmacol; 1981 Feb; 31(2):313-29. PubMed ID: 7221185
[TBL] [Abstract][Full Text] [Related]
29. [Preventive effect of prostaglandin E1 on cisplatin-induced nephrotoxicity].
Takayama K; Nakanishi Y; Takano K; Harada T; Inoue K; Osaki S; Minami T; Hara N
Gan To Kagaku Ryoho; 1999 Mar; 26(4):503-8. PubMed ID: 10097747
[TBL] [Abstract][Full Text] [Related]
30. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
31. [Urinary NAG activity and diabetic microangiopathy].
Clemenzia G; Laterza G; Cottone G; Scibinetti F; Russo G; Persichetti S; Sagliaschi G; Re M; Gallo G; Gallo E
Minerva Med; 1987 Oct; 78(19):1453-5. PubMed ID: 3670689
[TBL] [Abstract][Full Text] [Related]
32. [Clinical relevance of N-acetylglucosaminidase determination in urine of kidney transplant recipients with and without cyclosporin A].
Loertscher R; Scholer A; Brunner F; Harder F; Thiel G
Schweiz Med Wochenschr; 1982 Nov; 112(46):1658-64. PubMed ID: 6760389
[TBL] [Abstract][Full Text] [Related]
33. [Isoenzymes of N-acetyl-beta-D-glucosaminidase (NAG): new method of evaluating the nephrotoxicity of aminosides. Our experience with dibekacin in geriatrics].
Gibey R; Dupond JL; Mallet H; Guerber F; Iehl-Robert M; Flausse-Parrot F; Becker M
Nephrologie; 1986; 7(2):51-5. PubMed ID: 3736764
[TBL] [Abstract][Full Text] [Related]
34. [Chemotherapy of metastatic urothelial carcinoma. cis-Diamminedichloroplatinum combination chemotherapy for patients with decreased renal function].
Kihara K; Kusuyama H; Washizuka M; Kawai T
Hinyokika Kiyo; 1984 Jan; 30(1):21-8. PubMed ID: 6539559
[TBL] [Abstract][Full Text] [Related]
35. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases].
Zandvliet EE; Giesberts MA; van Gelderen HH
Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088
[TBL] [Abstract][Full Text] [Related]
36. [Urinary excretion of N-acetyl-beta-D-glucosaminidase in patients with urological disease: with special reference to hydronephrosis].
Ueda K; Kato J; Seki T
Hinyokika Kiyo; 1984 Jul; 30(7):877-82. PubMed ID: 6391119
[TBL] [Abstract][Full Text] [Related]
37. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing.
Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ
Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382
[TBL] [Abstract][Full Text] [Related]
38. [Relationship between plasma and urinary platinum pharmacokinetics with cisplatin nephrotoxicity in breast cancer patients].
Guo JH
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):150-3. PubMed ID: 1618086
[TBL] [Abstract][Full Text] [Related]
39. [Study on N-acetyl-beta-glucosaminidase (NAG) activity in urine. I. Methodological study and normal values].
Uno E; Sano K
Rinsho Byori; 1983 Dec; 31(12):1325-9. PubMed ID: 6676486
[No Abstract] [Full Text] [Related]
40. The excretion of N-acetyl-beta-glucosaminidase in glomerulonephritis.
Hultberg B; Ravnskov U
Clin Nephrol; 1981 Jan; 15(1):33-8. PubMed ID: 7214750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
